81 related articles for article (PubMed ID: 27883876)
21. Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden.
Liang WS; Vergilio JA; Salhia B; Huang HJ; Oki Y; Garrido-Laguna I; Park H; Westin JR; Meric-Bernstam F; Fabrizio D; Miller VA; Stephens PJ; Fanale MA; Ross JS; Janku F
Oncologist; 2019 Feb; 24(2):219-228. PubMed ID: 30108156
[TBL] [Abstract][Full Text] [Related]
22. Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting.
He J; Abdel-Wahab O; Nahas MK; Wang K; Rampal RK; Intlekofer AM; Patel J; Krivstov A; Frampton GM; Young LE; Zhong S; Bailey M; White JR; Roels S; Deffenbaugh J; Fichtenholtz A; Brennan T; Rosenzweig M; Pelak K; Knapp KM; Brennan KW; Donahue AL; Young G; Garcia L; Beckstrom ST; Zhao M; White E; Banning V; Buell J; Iwanik K; Ross JS; Morosini D; Younes A; Hanash AM; Paietta E; Roberts K; Mullighan C; Dogan A; Armstrong SA; Mughal T; Vergilio JA; Labrecque E; Erlich R; Vietz C; Yelensky R; Stephens PJ; Miller VA; van den Brink MR; Otto GA; Lipson D; Levine RL
Blood; 2016 Jun; 127(24):3004-14. PubMed ID: 26966091
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapy.
Hilal T; Nakazawa M; Hodskins J; Villano JL; Mathew A; Goel G; Wagner L; Arnold SM; DeSimone P; Anthony LB; Hosein PJ
BMC Cancer; 2017 Aug; 17(1):602. PubMed ID: 28854908
[TBL] [Abstract][Full Text] [Related]
24. Oncogenic alterations in ERBB2/HER2 represent potential therapeutic targets across tumors from diverse anatomic sites of origin.
Chmielecki J; Ross JS; Wang K; Frampton GM; Palmer GA; Ali SM; Palma N; Morosini D; Miller VA; Yelensky R; Lipson D; Stephens PJ
Oncologist; 2015 Jan; 20(1):7-12. PubMed ID: 25480824
[TBL] [Abstract][Full Text] [Related]
25. Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer.
Vignot S; Frampton GM; Soria JC; Yelensky R; Commo F; Brambilla C; Palmer G; Moro-Sibilot D; Ross JS; Cronin MT; André F; Stephens PJ; Lazar V; Miller VA; Brambilla E
J Clin Oncol; 2013 Jun; 31(17):2167-72. PubMed ID: 23630207
[TBL] [Abstract][Full Text] [Related]
26. WWOX expression in giant cell lesions of the jaws.
Amaral FR; Diniz MG; Bernardes VF; Souza PE; Gomez RS; Gomes CC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):210-3. PubMed ID: 23849374
[TBL] [Abstract][Full Text] [Related]
27. Illumina whole-genome complementary DNA-mediated annealing, selection, extension and ligation platform: assessing its performance in formalin-fixed, paraffin-embedded samples and identifying invasion pattern-related genes in oral squamous cell carcinoma.
Loudig O; Brandwein-Gensler M; Kim RS; Lin J; Isayeva T; Liu C; Segall JE; Kenny PA; Prystowsky MB
Hum Pathol; 2011 Dec; 42(12):1911-22. PubMed ID: 21683979
[TBL] [Abstract][Full Text] [Related]
28. The highly prevalent H3F3A mutation in giant cell tumours of bone is not shared by sporadic central giant cell lesion of the jaws.
Gomes CC; Diniz MG; Amaral FR; Antonini Guimarães BV; Gomez RS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Nov; 118(5):583-5. PubMed ID: 25442495
[TBL] [Abstract][Full Text] [Related]
29. Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms.
Young G; Wang K; He J; Otto G; Hawryluk M; Zwirco Z; Brennan T; Nahas M; Donahue A; Yelensky R; Lipson D; Sheehan CE; Boguniewicz AB; Stephens PJ; Miller VA; Ross JS
Cancer Cytopathol; 2013 Dec; 121(12):688-94. PubMed ID: 23893923
[TBL] [Abstract][Full Text] [Related]
30. Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies.
Ali SM; Sanford EM; Klempner SJ; Rubinson DA; Wang K; Palma NA; Chmielecki J; Yelensky R; Palmer GA; Morosini D; Lipson D; Catenacci DV; Braiteh F; Erlich R; Stephens PJ; Ross JS; Ou SH; Miller VA
Oncologist; 2015 May; 20(5):499-507. PubMed ID: 25882375
[TBL] [Abstract][Full Text] [Related]
31. Immunoexpression of calcitonin and glucocorticoid receptors in central giant cell lesions of the jaws.
Batista Severo ML; Lopes MLDS; Miguel MCDC; Germano AR; Nogueira RLM; Turatti E; Cavalcante RB; da Silveira ÉJD
J Oral Pathol Med; 2018 Oct; 47(9):907-913. PubMed ID: 30028524
[TBL] [Abstract][Full Text] [Related]
32. Cytomorphometric and immunohistochemical comparison between central and peripheral giant cell lesions of the jaws.
Flórez-Moreno GA; Henao-Ruiz M; Santa-Sáenz DM; Castañeda-Peláez DA; Tobón-Arroyave SI
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 May; 105(5):625-32. PubMed ID: 18299236
[TBL] [Abstract][Full Text] [Related]
33. Cyclooxygenase-2 expression in central giant cell lesion of the jaws: an immunohistochemical study.
Nogueira RL; Faria MH; Osterne RL; Cavalcante RB; Ribeiro RA; Rabenhorst SH
J Mol Histol; 2012 Feb; 43(1):59-62. PubMed ID: 22042094
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies.
Ross JS; Ali SM; Wang K; Palmer G; Yelensky R; Lipson D; Miller VA; Zajchowski D; Shawver LK; Stephens PJ
Gynecol Oncol; 2013 Sep; 130(3):554-9. PubMed ID: 23791828
[TBL] [Abstract][Full Text] [Related]
35. Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania 'Luigi Vanvitelli'.
De Falco V; Poliero L; Vitello PP; Ciardiello D; Vitale P; Zanaletti N; Giunta EF; Terminiello M; Caputo V; Carlino F; Di Liello R; Ventriglia A; Famiglietti V; Martinelli E; Morgillo F; Orditura M; De Vita F; Fasano M; Napolitano S; Martini G; Della Corte CM; Franco R; Altucci L; Ciardiello F; Troiani T
ESMO Open; 2020 Mar; 5(2):. PubMed ID: 32234730
[TBL] [Abstract][Full Text] [Related]
36. Do histologic criteria predict biologic behavior of giant cell lesions?
Peacock ZS; Resnick CM; Susarla SM; Faquin WC; Rosenberg AE; Nielsen GP; Schwab JH; Hornicek F; Ebb DH; Dodson TB; Kaban LB
J Oral Maxillofac Surg; 2012 Nov; 70(11):2573-80. PubMed ID: 22365980
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical evaluation of giant cell tumors of the jaws using CD34 density analysis.
Dewsnup NC; Susarla SM; Abulikemu M; Faquin WC; Kaban LB; August M
J Oral Maxillofac Surg; 2008 May; 66(5):928-33. PubMed ID: 18423282
[TBL] [Abstract][Full Text] [Related]
38. Concordance between Comprehensive Cancer Genome Profiling in Plasma and Tumor Specimens.
Müller JN; Falk M; Talwar J; Neemann N; Mariotti E; Bertrand M; Zacherle T; Lakis S; Menon R; Gloeckner C; Tiemann M; Heukamp LC; Thomas RK; Griesinger F; Heuckmann JM
J Thorac Oncol; 2017 Oct; 12(10):1503-1511. PubMed ID: 28751246
[TBL] [Abstract][Full Text] [Related]
39. Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.
Gast A; Scherer D; Chen B; Bloethner S; Melchert S; Sucker A; Hemminki K; Schadendorf D; Kumar R
Genes Chromosomes Cancer; 2010 Aug; 49(8):733-45. PubMed ID: 20544847
[TBL] [Abstract][Full Text] [Related]
40. Maxillofacial and axial/appendicular giant cell lesions: unique tumors or variants of the same disease?--A comparison of phenotypic, clinical, and radiographic characteristics.
Resnick CM; Margolis J; Susarla SM; Schwab JH; Hornicek FJ; Dodson TB; Kaban LB
J Oral Maxillofac Surg; 2010 Jan; 68(1):130-7. PubMed ID: 20006167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
